Vitamin C
In a statement Monday, Jared Shapiro, a Lilly spokesperson, said all doses of Mounjaro and Zepbound are available, warning that its important that patients not be exposed to the risks in taking untested, unapproved knockoffs. Nothing changes the fact that, as FDA has recognized, Mounjaro and Zepbound are available and the shortage remains resolved, Shapiro said
Dulaglutide may support weight loss by slowing digestion and reducing appetite through its effects on GLP-1 receptors in the brain and digestive system
Exenatide was the first drug introduced in the GLP-1 receptor agonist class
Kaya C, Ashraf M, Alyemeni MN, Ahmad P
This evidence supports expanding access to semaglutide for cardiovascular protection beyond traditional weight-loss indications, potentially benefiting millions of patients with established cardiovascular disease regardless of their ability to lose weight on the medication